Cargando…
Stabilizers of edaravone aqueous solution and their action mechanisms. 2. Glutathione
Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) has garnered attention since its approval for amyotrophic lateral sclerosis in Japan (2015) and the United States (2017). Edaravone is administered intravenously, and as such, is distributed in the form of an aqueous solution. However, aqueous solution...
Autores principales: | Tanaka, Masahiko, Motomiya, Satsuki, Fujisawa, Akio, Yamamoto, Yorihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703789/ https://www.ncbi.nlm.nih.gov/pubmed/29203956 http://dx.doi.org/10.3164/jcbn.17-75 |
Ejemplares similares
-
Stabilizers of edaravone aqueous solution and their action mechanisms. 1. Sodium bisulfite
por: Tanaka, Masahiko, et al.
Publicado: (2017) -
4-Cl-edaravone and (E)-2-chloro-3-[(E)-phenyldiazenyl]-2-butenoic acid are the specific reaction products of edaravone with hypochlorite
por: Amekura, Sakiko, et al.
Publicado: (2020) -
Edaravone, a scavenger for multiple reactive oxygen species, reacts with singlet oxygen to yield 2-oxo-3-(phenylhydrazono)-butanoic acid
por: Amekura, Sakiko, et al.
Publicado: (2022) -
How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
por: Watanabe, Kazutoshi, et al.
Publicado: (2018) -
Plasma marker of tissue oxidative damage and edaravone as a scavenger drug against peroxyl radicals and peroxynitrite
por: Yamamoto, Yorihiro
Publicado: (2017)